Lee's Pharmaceutical Limited
Quick facts
| Founded | 2002 |
|---|
Marketed products
- Aspirine · Other
- Clindamycin Gel
- Enantone · Other
- Felodipine sustained-release tablet
- Iron protein succinylate oral solution · Hematology
Iron protein succinylate provides bioavailable iron in a protein-chelated form to treat iron deficiency by replenishing iron stores. - Levocarnitine Injection
- Lutrate · Other
- Olmesartan medoxomil tablets · Cardiovascular
Olmesartan medoxomil blocks angiotensin II type 1 (AT1) receptors, preventing vasoconstriction and reducing blood pressure. - Zanidip · Cardiovascular
Phase 3 pipeline
- Azilsartan tablets · Cardiovascular
Azilsartan blocks angiotensin II type 1 (AT1) receptors, preventing vasoconstriction and reducing blood pressure. - intravaginal prasterone · Gynecology
Intravaginal prasterone is a vaginal progesterone that mimics the natural hormone progesterone to treat symptoms of menopause. - Lidocaine (Zingo) · Anesthesia / Pain Management
Lidocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses. - Placebo+cisplatin/carboplatin+paclitaxel+Bevacizumab · Oncology
This combination regimen uses platinum-based chemotherapy and a taxane to damage cancer cell DNA, combined with an anti-angiogenic monoclonal antibody to block tumor blood vessel formation. - Placebo ovules
Placebo ovules contain inert ingredients with no active pharmaceutical component and produce therapeutic effects primarily through the placebo effect. - Propionyl-L-carnitine Tablets · Cardiovascular
Propionyl-L-carnitine is a carnitine derivative that may improve blood flow and reduce oxidative stress. - Socazolimab+cisplatin/carboplatin+paclitaxel+Bevacizumab · Oncology
Socazolimab is a PD-1 inhibitor monoclonal antibody, while Bevacizumab is a VEGF inhibitor monoclonal antibody. Paclitaxel is a microtubule inhibitor, and cisplatin/carboplatin are platinum-based DNA crosslinking agents. - ZKAB001 · Unknown
ZKAB001 is a small molecule drug that targets the molecular target.
Phase 2 pipeline
Phase 1 pipeline
- anti-PD-L1 antibody
- AU409
- Natulan · Other
- Pazufloxacin Mesilate ear drops
- Pexa-Vec combined with ZKAB001
- Propionyl L-carnitine Hydrochloride
- TAB014
- TG02 capsules oral administration, BIW in every 28d
- trazodone hydrochloride prolonged-release tablet
- Trazodone Hydrochloride prolonged-release tablets
- ZKAB001 monotherapy
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: